Cargando…
Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation
Many clinically relevant therapeutic agents are formed from the conjugation of small molecules to biomolecules through conjugating linkers. In this study, two novel conjugating linkers were prepared, comprising a central coumarin core, functionalized with a dimaleimide moiety at one end and a termin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175205/ https://www.ncbi.nlm.nih.gov/pubmed/32121143 http://dx.doi.org/10.3390/biom10030369 |
_version_ | 1783524783612231680 |
---|---|
author | Tsao, Kelvin K. Lee, Ann C. Racine, Karl É. Keillor, Jeffrey W. |
author_facet | Tsao, Kelvin K. Lee, Ann C. Racine, Karl É. Keillor, Jeffrey W. |
author_sort | Tsao, Kelvin K. |
collection | PubMed |
description | Many clinically relevant therapeutic agents are formed from the conjugation of small molecules to biomolecules through conjugating linkers. In this study, two novel conjugating linkers were prepared, comprising a central coumarin core, functionalized with a dimaleimide moiety at one end and a terminal alkyne at the other. In our first design, we developed a protein labelling method that site-specifically introduces an alkyne functional group to a dicysteine target peptide tag that was genetically fused to a protein of interest. This method allows for the subsequent attachment of azide-functionalized cargo in the facile synthesis of novel protein-cargo conjugates. However, the fluorogenic aspect of the reaction between the linker and the target peptide was less than we desired. To address this shortcoming, a second linker reagent was prepared. This new design also allowed for the site-specific introduction of an alkyne functional group onto the target peptide, but in a highly fluorogenic and rapid manner. The site-specific addition of an alkyne group to a protein of interest was thus monitored in situ by fluorescence increase, prior to the attachment of azide-functionalized cargo. Finally, we also demonstrated that the cargo can also be attached first, in an azide/alkyne cycloaddition reaction, prior to fluorogenic conjugation with the target peptide-fused protein. |
format | Online Article Text |
id | pubmed-7175205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71752052020-04-28 Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation Tsao, Kelvin K. Lee, Ann C. Racine, Karl É. Keillor, Jeffrey W. Biomolecules Article Many clinically relevant therapeutic agents are formed from the conjugation of small molecules to biomolecules through conjugating linkers. In this study, two novel conjugating linkers were prepared, comprising a central coumarin core, functionalized with a dimaleimide moiety at one end and a terminal alkyne at the other. In our first design, we developed a protein labelling method that site-specifically introduces an alkyne functional group to a dicysteine target peptide tag that was genetically fused to a protein of interest. This method allows for the subsequent attachment of azide-functionalized cargo in the facile synthesis of novel protein-cargo conjugates. However, the fluorogenic aspect of the reaction between the linker and the target peptide was less than we desired. To address this shortcoming, a second linker reagent was prepared. This new design also allowed for the site-specific introduction of an alkyne functional group onto the target peptide, but in a highly fluorogenic and rapid manner. The site-specific addition of an alkyne group to a protein of interest was thus monitored in situ by fluorescence increase, prior to the attachment of azide-functionalized cargo. Finally, we also demonstrated that the cargo can also be attached first, in an azide/alkyne cycloaddition reaction, prior to fluorogenic conjugation with the target peptide-fused protein. MDPI 2020-02-28 /pmc/articles/PMC7175205/ /pubmed/32121143 http://dx.doi.org/10.3390/biom10030369 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tsao, Kelvin K. Lee, Ann C. Racine, Karl É. Keillor, Jeffrey W. Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation |
title | Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation |
title_full | Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation |
title_fullStr | Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation |
title_full_unstemmed | Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation |
title_short | Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation |
title_sort | site-specific fluorogenic protein labelling agent for bioconjugation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175205/ https://www.ncbi.nlm.nih.gov/pubmed/32121143 http://dx.doi.org/10.3390/biom10030369 |
work_keys_str_mv | AT tsaokelvink sitespecificfluorogenicproteinlabellingagentforbioconjugation AT leeannc sitespecificfluorogenicproteinlabellingagentforbioconjugation AT racinekarle sitespecificfluorogenicproteinlabellingagentforbioconjugation AT keillorjeffreyw sitespecificfluorogenicproteinlabellingagentforbioconjugation |